Rigel Pharmaceuticals reported $19.83M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US USD -20385000 23.8M
Amgen AMGN:US USD 3.65B 1.23B
Anika Therapeutics ANIK:US USD 284.94M 1.22M
Applied Genetic Technologies AGTC:US USD 17.65M 11.83M
Arrowhead Research ARWR:US USD 398.52M 55.41M
Astrazeneca AZN:US USD 35.13B 798M
AstraZeneca AZN:LN USD 35.13B 798M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Celldex Therapeutics CLDX:US USD 345.42M 19.68M
Daiichi Sankyo 4568:JP JPY 1.47T 66.9B
Eli Lilly And LLY:US USD 10.07B 1.53B
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Immunogen IMGN:US USD 178.01M 71.82M
Intrexon XON:US USD 142.53M 86.88M
Karyopharm Therapeutics KPTI:US USD -140280000 23.94M
Ligand Pharmaceuticals LGND:US USD 816.3M 13.93M
Macrogenics MGNX:US USD 122.96M 19.52M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Rigel Pharmaceuticals RIGL:US USD 19.83M 23.51M
Sangamo Biosciences SGMO:US USD 309.15M 9.13M
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
Veracyte VCYT:US USD 1.05B 15.97M